BioMed Research International

BioMed Research International / 2013 / Article
Special Issue

Particulate Matter and Nanoparticles Toxicology

View this Special Issue

Research Article | Open Access

Volume 2013 |Article ID 158093 | 9 pages |

Release of IL-1β Triggered by Milan Summer PM10: Molecular Pathways Involved in the Cytokine Release

Academic Editor: Per Schwarze
Received02 Oct 2012
Revised22 Dec 2012
Accepted03 Jan 2013
Published06 Feb 2013


Particulate matter (PM) exposure is related to pulmonary and cardiovascular diseases, with increased inflammatory status. The release of the proinflammatory interleukin- (IL-) 1β, is controlled by a dual pathway, the formation of inactive pro-IL-1β, through Toll-like receptors (TLRs) activation, and its cleavage by NLRP3 inflammasome. THP-1-derived macrophages were exposed for 6 h to 2.5 μg/cm2 of Milan PM10, and the potential to promote IL-1β release by binding TLRs and activating NLRP3 has been examined. Summer PM10, induced a marked IL-1β response in the absence of LPS priming (50-fold increase compared to unexposed cells), which was reduced by caspase-1 inhibition (91% of inhibition respect summer PM10-treated cells) and by TLR-2 and TLR-4 inhibitors (66% and 53% of inhibition, resp.). Furthermore, summer PM10 increased the number of early endosomes, and oxidative stress inhibition nearly abolished PM10-induced IL-1β response (90% of inhibition). These findings suggest that summer PM10 contains constituents both related to the activation of membrane TLRs and activation of the inflammasome NLPR3 and that TLRs activation is of pivotal importance for the magnitude of the response. ROS formation seems important for PM10-induced IL-1β response, but further investigations are needed to elucidate the molecular pathway by which this effect is mediated.

1. Introduction

In the last decade great effort has been paid to understand the mechanisms involved in particulate matter (PM) induced adverse health effects. Epidemiological evidence shows an association between exposure to air pollution and the occurrence of respiratory pathologies (chronic bronchitis, COPD) and exacerbation of allergic conditions such as asthma [13]. Furthermore, many studies also show an association between PM atherothrombotic effects, cardiovascular morbidity, and mortality [46].

PM is a heterogeneous pollutant composed of particles of different chemical composition and different sizes (defined as PM10, PM2.5, and PM0.1 for their aerodynamic diameter). Although the size determines the site of deposition of PM in the respiratory tract [7], the chemical composition of the inhaled particles is considered of primary importance in determining the adverse biological effects [8, 9]. The chemical properties of PM are strongly related to the sources of emission of the particles, and this is known to be crucial for the differences of the PM effects from different sampling sites [1013].

The fine fraction (PM2.5) is generally composed of primary particles derived from combustion processes, mostly consisting of primary particles with mean diameter lower than 100 nm (PM0.1, ultrafine particles) and secondary aerosol deriving from chemical reaction of free compounds in the atmosphere. The particle composition reflects the sources of emission; indeed fine PM has usually higher content in organic compounds (such as PAHs) and elemental carbon (the soot core of the particles) than the coarse PM.

The coarse fraction (PM10–2.5) is on the contrary dominated by particles derived from abrasion processes, such as the erosion of crustal material, resuspension of deposited particles, and biological components. We have previously shown that the season of PM sampling strongly influences the chemical and biological composition of both coarse and fine PMs [14, 15]. In fact summer and winter PM10 fractions showed a completely different composition in chemical and biological constituents, the latter being higher in summer PM10 [11, 16, 17].

Moreover, the chemical characterization showed that the PM10 contained crystal silica and other elements which can contribute to its inflammatory potential.

A lot of studies have shown that PM10 exposure promotes inflammation in the lung which is associated with a systemic inflammatory response. Macrophages and lung epithelial cells incubated with PM10 release significantly increased amounts of cytokines and chemokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin IL-1β, IL-6, and IL-8, and macrophage chemo-attractant protein (MCP)-1 [18]. An increased lung inflammation is known to be fundamental for the development of different lung diseases, such as COPD [1921]. However, despite the increased evidence that the coarse fraction of PM is potent in inducing lung inflammation, a model explaining its effects has not been completely understood.

A critical property of the innate immune system is its ability to discriminate microbes from “self” by the recognition of invariant microbial structure called pathogen-associated recognition patterns (PAMPs) such as lipopolysaccharides (LPS) [22]. The sensing of these PAMPs is usually mediated by the membrane-bounded Toll-like receptors (TLRs), such as TLR-2 and TLR-4 [23, 24]. Commonly these receptors trigger the activation of the NF-kB pathway which determines the release of different proinflammatory proteins, such as pro-IL-1β. Another set of pattern recognition receptors are the cytoplasm Nod-like receptors. These receptors have been demonstrated to be key proteins in the activation of pro-caspase-1, through the formation of the caspase-1 activating platforms, the inflammasomes. The inflammasomes control in turn the cleavage and secretion of potent proinflammatory interleukins such as IL-1β and IL-18. Among the different inflammasomes, the NLRP3 (or NALP3) is the most characterized. This complex is composed of a basic scaffold, the adaptor molecule apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), and the caspase-1. The activation of this complex has been related to the exposure of different PAMPs as well as host-derived molecules [25].

IL-1β is released at the site of injury, or immunological challenge is coordinating inflammatory responses, such as the recruitment of other cells to the site of infection or injury [26], and is known to be crucial in development of different diseases, including silicosis [27, 28]. IL-1β is also, however, known to regulate sleep, appetite, and body temperature. Due to its potent activities, it is not surprisingly that IL-1β activity is rigorously controlled throughout its entire release pathway, from expression to maturation and final secretion.

The activation of the inflammasome machinery has been related to different mechanisms which have been reviewed in [25]. However for the release of IL-1β a priming stimulus is required for the formation of pro-IL-1β as reported in [29].

It has been shown that particles occurring in ambient PM, such as crystalline silica, as well as different nanoparticles, may induce inflammasome activation [20, 3033]. The potential role of the inflammasome in PM-induced inflammation is however not known. Reactive oxygen substances (ROS) are known to be involved in PM10-induced inflammation [34, 35] and also in silica-induced inflammasome activation [21, 36]. Potentially ROS might be involved in the pro-IL-1β formation as well as the inflammasome activation [37, 38].

In the present study it was hypothesized that PM10 due to its chemical and physical nature might induce IL-1β release. Summer Milan PM10 contains both endotoxins, which might activate TLR receptors, and elemental and crustal constituents, which might activate the inflammasome mechanism. Furthermore, it is hypothesized that ROS is involved in PM10-induced IL-1β responses.

2. Materials and Methods

2.1. Cell Culture and Treatments

The human monocytes cell line, THP-1, was maintained in Opti-MEM medium supplemented with 10% FBS and 100 U/100 mL Penicillin/Streptomycin at 37°C, 5% CO2. THP-1 cells were differentiated into macrophage-like cells by incubation with phorbol myristate acetate (PMA, 20 nM) (Sigma Aldrich) for 24 h. PMA was then removed and cells were washed and incubated in Opti-MEM (Invitrogen, Italy) medium supplemented with 20% FBS o/n. Cells were treated in 10% FBS medium with summer PM10 at different concentrations (1 μg/cm2, 2.5 μg/cm2, and 5 μg/cm2) for different times of exposure (30 min, 2 h, 4 h, and 6 h). Winter PM10 and carbon black (CB, 2–12 μm, Sigma Aldrich, Italy) were used (5 μg/cm2) as comparison and reference particles, respectively. In order to investigate TLR-2, TLR-4 and caspase-1 involvement in IL-1β release, cells were pre-treated for 1 h with inhibitors of TLR-2 and TLR-4 (0, 1 μg/mL, R&D Systems) and caspase-1 (z-YVAD-fmk, 10 μM, Calbiochem) and then exposed to summer PM10 (2.5 μg/cm2). Summer and winter PM10 particles have been characterised as previously reported in [39] and [40] respectively. ROS involvement in IL-1β release was assessed by treating PM10 exposed cells with N-acetylcysteine (NAC, 15 mM, 30 min prior to PM exposure).

2.2. IL-1β Release

Supernatants from control and PM10-exposed cells were collected and stored at −80°C. Supernatants were assayed for IL-1β with ELISA kits (Invitrogen Srl) according to manufacturer’s instructions.

2.3. Endocytic Pathway Analysis
2.3.1. Immunostaining

After 30 min exposure to summer PM10, cells were washed in phosphate-buffered saline 1X (PBS), fixed in paraformaldehyde 4% for 20 min, and washed twice in PBS. Fixed cells were permeabilized with 0.1% Triton X-100 (Sigma Aldrich), 0.1% Tween (Sigma Aldrich), and 2% BSA (Sigma Aldrich) in PBS and incubated o/n with the rabbit anti-human early endosome antibody 1 (EEA1 Antibody, Cell Signaling Technology; dilution 1 : 100). Cells were then washed in PBS and incubated with Alexa fluor-488 (Invitrogen Molecular Probes Srl; dilution 1 : 1000) for 2 h. Samples were mounted on a slide with ProLong mount (Invitrogen Srl) and observed by Axio Observer inverted microscope (Zeiss, Germany).

2.3.2. Western Blot

After exposure to summer PM10 cells were washed in PBS and stored at −80°C. Cells were then lysed in RIPA buffer (50 mM Tris-HCl pH 8; 150 mM NaCl; 1% NP-40; 0.5% sodium deoxycholate; 0.1% SDS; Sigma Ladrich Italy) and then sonicated three times for 30 sec on ice. Cell lysates were then separated by 8% SDS-PAGE and transferred on nitrocellulose membranes. Blots were incubated with rabbit polyclonal antibody against human EEA1 (Cell Signaling Technology; dilution 1 : 1000) o/n or anti-actin antibody (Sigma Aldrich, Italy; dilution 1 : 2000). After washes, the membranes were incubated with secondary antibody anti-rabbit IgG (Fab2 fragment-Alkaline Phosphatase, Sigma Aldrich; dilution 1 : 10000) and subsequently incubated with SIGMA FAST BCIP/NBT alkaline phosphatase substrate (Sigma Aldrich) for 10 min for detection. Fold increase data over control, obtained by acquisition of membrane and densitometry analysis with dedicated software (UVP, US), were normalized to the actin content.

2.4. Cells-Particles Interaction
2.4.1. Haematoxylin-Eosin Staining

THP-1-derived macro-phage untreated and treated with summer PM10 for 24 h at the concentration of 2.5 μg/cm2, were fixed in paraformaldehyde 4% for 20 min and then stained following haematoxylin-eosin protocol and then observed under an Axiolab light microscope (Zeiss, Germany).

2.4.2. Transmission Electron Microscopy

Samples were prepared for transmission electron microscopy (TEM) using standard procedures. At the end of exposure the cells were fixed in 2.5% glutaraldehyde for 20 min at 4°C and postfixed with 1% osmium tetroxide for 1 h, followed by dehydration using a scale of graded ethanol. Cells were then embedded in Epon resin, and semithin and ultrathin sections were prepared by an ultramicrotome (Ultracut Jung E, Reichert Germany). Ultrathin slides were mounted on copper grids and counterstained by lead citrate and uranyl acetate prior to examination by Jeol JEM 1220 microscope operating at 80 kV and digital images were taken with a Gatan CCD camera.

2.5. Statistical Analysis

Results are reported as mean ± standard deviation of at least three independent experiments. Statistical differences were analysed by the software SigmaStat 3.1 performing ANOVA test with post hoc analysis (Dunn’s); if required a parametric statistical analysis was performed.

3. Results

3.1. Release of IL-1β from Human Macrophage-Like Cell after Summer Milan PM10 Exposure

THP-1-derived macrophages were treated as reported with summer Milan PM10 and with winter PM10 and CB. The experiments showed that IL-1β was dose-dependently increased after summer Milan PM10 treatment, with a progressive increase from 1 to 5 μg/cm2. In contrast, winter Milan PM10 and CB did not induce significant release of the interleukin (Figure 1). Cells were then exposed to 2.5 μg/cm2 of summer Milan PM10, chosen as the first dose of effects, to investigate the time-course release of IL-1β. The IL-1β release showed a progressive increase from 2 to 6 h (Figure 2).

3.2. IL-1β Release and Inhibition of Caspase-1, TLR-2/-4 and Oxidative Stress

THP-1-derived macrophages were pre-treated for 1 h with the caspase-1 inhibitor z-YVAD (10 μM) and then treated with summer PM10 (2.5 μg/cm2) for 6 h, or only with z-YVAD. Cells preexposed with z-YVAD showed IL-1β release similar to the control (data not shown). The experiments showed that z-YVAD significantly reduced summer PM10-induced release of IL-1β (approximately 90%), compared to PM10 treatment alone (Figure 3).

Subsequently THP-1-derived macrophages were pretreated with TLR-2 and TLR-4 inhibitors (0.1 μg/mL) for 1 h before exposure to summer PM10 (2.5 μg/cm2 for 6 h). The inhibition of the TLR receptors significantly reduced the release of IL-1β induced by summer Milan PM10 (Figure 4). The TLR-2 inhibitor was more potent than the TLR-4 inhibitor. Furthermore, combining the two inhibitors gave the maximal reduction of IL-1β release. The TLR inhibitors did not affect the IL-1β release from control cells (data not shown).

Treatment with NAC, an inhibitor of oxidative stress, reduced the release of IL-1β in THP-1-derived macrophages treated with PM10 to control levels (Figure 5).

3.3. Cells-Particles Interaction: Endocytosis Pathway

We focused our study also on the molecular mechanisms involved in summer Milan PM10-induced IL-1β release.

The activity of early endosomes after the exposure to summer PM10 was examined by analysing the expression of the early endosome antigen 1 (EEA1) in THP-1-derived macrophages. The cells were exposed to summer PM10 for 30 min and then assessed by EEA1 immunostaining. We observed that EEA1 expression after 30 min was remarkably increased compared to the control (Figure 6). This result is also confirmed by immunoblotting of EEA1. The cells were treated with summer PM10 (2.5 μg/cm2) for 2 to 6 h and assessed for EEA1 expression by Western analysis. The data show that the EEA1 is overexpressed from 30 min to 4 h, but was approximately similar to the control at 6 h (Figure 7). These results suggest that THP-1-derived macrophages are able to phagocytise summer PM10 and its internalization involves early endosomes.

3.4. Cell Particles Interaction

The interaction between summer Milan PM10 and THP-1-derived macrophages was determined by haematoxylin-eosin staining and electron transmission microscopy (TEM). Haematoxylin-eosin-stained macrophages exposed to summer PM10 (for 6 h) showed a high number of particles attached to the cells (Figures 8(b) and 8(c)). TEM picture demonstrated the internalization of summer PM10 particles in cytoplasm vesicles and also translocation of small aggregates in the nucleus (Figure 8(d)). The TEM picture showed also a clear interaction of summer PM10 with plasma membranes with the formation of phagocyte structures (Figure 8(e)).

4. Discussion

Recently PM10 was demonstrated to induce IL-1β release via an inflammasome mechanism as revealed by caspase-1 inhibition and siRNA against NALP3 in THP-1 cells and by NALP3 knockout mice. The potential of PM10 was however relatively slight, about 3-fold using 500 μg/mL [35]. Compared to this we report that PM10 collected in the summer in Milan induced a massive IL-1β response (a 50-fold increase, at 10-fold lower concentrations) in THP-1-derived macrophages. However, PM10 collected in Milan in the winter showed only a slight IL-1β response, underlining the importance of the PM10 sources. Our study also indicates the importance of an inflammasome mechanism, as the response was reduced by caspase- 1 inhibition. It is however suggested that the summer Milan PM10-induced activation of TLR-2 and TLR-4 receptors, leading to synthesis of pro-IL-1β, is the major determinant for the massive response induced by summer Milan PM10. Furthermore, our study showed a role for oxidative stress in the PM10-induced IL-1β release.

Most of the in vitro studies of particle-induced IL-1β responses have primed the cells with the endotoxins like LPS to increase the pool of pro-IL-1β before exposing to different agents capable of inducing the inflammasome mechanism. Indeed, for both crystalline and amorphous silica particles [20, 30], the priming of exposed cells with bacterial LPS is essential for the release of IL-1β following the activation of the inflammasome. It is now emerging in a lot of studies that different nanoparticles and other agents might activate the inflammasome mechanism, and induce large IL-1β responses in LPS-primed cells [30, 41]. In the present study it is also shown that the activation of the inflammasome is a crucial mechanism for the PM10-induced IL-1β response, as the caspase-1 inhibitor z-YVAD reduced the interleukin release. Furthermore, PM10 induced a marked increase in endosomes internalization that has been shown to be involved in the inflammasome pathway [22, 42]. The most striking in this study is however that the marked IL-1β response is observed in the absence of LPS-priming. This suggest that summer Milan PM10 contains constituents (endotoxins capable of the activation of TLR-2 and/or TLR-4) which lead to pro-IL-1β formation; in support of this, the suppression of TLRs activation by pretreating the cells with anti-TLR-2 and TLR-4 molecules induced a significant reduction of IL-1β release. Both the TLR-2 and 4 are receptors which role in recognition and binding of LPS, and other bacterial PAMPs have been extensively described [43, 44]. Since airways macrophages seldom recognize bacterial components individually, the response to different bacterial PAMPs is usually orchestrated by a combination of different TLRs. In fact we demonstrated that the combination of the two inhibitors seems to give the maximal reduction of IL-1β release after PM10 exposure. However, our data may indicate that other biological components or PAMPs and/or other membrane receptors may be involved in the priming of cells, since the reduction of TLR-2 and 4 activities did not abolish completely the final release of IL-1β. Indeed is has been reported that the activation of the different TRLs might be promoted by different molecules which can be found in PM [45]. The inhibition of TLR2 and 4 indicates the importance of these two receptors in summer Milan PM10-related effects, but the involvement of other TLRs cannot be excluded. Furthermore we have already reported [41] the presence of crustal elements in summer Milan PM10 which can promote proinflammatory responses.

Also, in the study of Hirota [35], a PM10-induced release of IL-1β is observed without LPS priming, but to a much less extent than for PM10 collected in Milan in the summer. In accordance with Hirota, we found a modest IL-1β response upon treatment to winter Milan PM10. The differential effects can presumably be attributed to the content of endotoxins in the PM10. In fact, we have previously reported that coarse fraction of summer PM10 is rich in Gram-negative bacteria, expressing LPS, in addition to crustal elements among which also silica [39, 46]. Interestingly, with respect to other end-points, like DNA damage and apoptotic cell death, we have shown that winter Milan PM10 is more potent than summer Milan PM10.

Oxidative stress seems to be crucial for the PM10-induced IL-1β response, as demonstrated by inhibition by the inhibitor NAC. In addition to generation of ROS by a cell-free mechanism, ROS may be generated via the mitochondrial pathway [47]. Upon rupturing the lysosome membrane, the ROS may also be released to the cytoplasm [21]. A critical question is whether the ROS exerts its effect on IL-1β release after PM10 treatment by affecting the lysosome pathway or the pathway from TLR activation to pro-IL-1β formation. The increased number of endosomes subsequent to PM10 exposure reported in this study could indicate a release of ROS via this pathway that may be linked to inflammasome mechanism. However, ROS scavengers, such as NAC, have been reported to interact more with the priming of the NLRP3 rather than its activation [48]. A better understanding of the importance of ROS in the TLR-activation, subsequent NF-kB activation, and synthesis of pro-IL-1β, versus activation of the inflammasome, is thus needed.

4.1. Concluding Remarks

Since IL-1β has been related to a number of human diseases, including different pulmonary pathologies [49], and PM is known to increase the development of lung disease [50], it is crucial to increase the understanding of the pathways involved. Our findings, with very marked effect of PM10 in absence of exogenous addition of LPS, suggest that summer Milan PM10 contains constituents both related to the activation of membrane TLRs and activation of the inflammasome NLPR3. Furthermore, our study suggests that the activation of TLRs is of much importance for explaining the magnitude of the PM10-induced IL-1β response. Thus, PM10 containing less biological components (PM10 sampled in winter) induces only a minor IL-1β response. The present study indicates an important role for ROS in PM10-induced IL-1β formation, but further investigations are needed to elucidate the origin of the ROS (by lysosomes rupture or other pathways), and to what extent the effect is mediated by inhibition of the NLP3 activation or the TLR-pro-IL-1β pathway, or a combination of both these pathways.

Conflict of Interests

The authors do not have any conflict of interests.

Authors’ Contribution

R. Bengalli, E. Molteni, and E. Longhin contributed equally to the in vitro experimental part. M. Gualtieri and R. Magne planned the in vitro experiments and contributed to the revision of the paper. M. Camatini and M. Gualtieri supervised the research activities during the Tosca Project.


M. Camatini and M. Gualtieri greatly thank Cariplo Foundation for financing the Tosca Project during which this research was performed.


  1. R. W. Atkinson, H. R. Anderson, J. Sunyer et al., “Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. 1860–1866, 2001. View at: Google Scholar
  2. B. Brunekreef and B. Forsberg, “Epidemiological evidence of effects of coarse airborne particles on health,” European Respiratory Journal, vol. 26, no. 2, pp. 309–318, 2005. View at: Publisher Site | Google Scholar
  3. K. Donaldson and W. MacNee, “Potential mechanisms of adverse pulmonary and cardiovascular effects of particulate air pollution (PM10),” International Journal of Hygiene and Environmental Health, vol. 203, no. 5-6, pp. 411–415, 2001. View at: Google Scholar
  4. R. D. Brook, S. Rajagopalan, C. A. Pope III et al., “Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the american heart association,” Circulation, vol. 121, pp. 2331–2378, 2010. View at: Publisher Site | Google Scholar
  5. C. A. Pope III, M. Ezzati, and D. W. Dockery, “Fine-particulate air pollution and life expectancy in the United States,” The New England Journal of Medicine, vol. 360, no. 4, pp. 376–386, 2009. View at: Publisher Site | Google Scholar
  6. A. Seaton, A. Soutar, V. Crawford et al., “Particulate air pollution and the blood,” Thorax, vol. 54, no. 11, pp. 1027–1032, 1999. View at: Google Scholar
  7. M. Lippmann, D. B. Yeates, and R. E. Albert, “Deposition, retention, and clearance of inhaled particles,” British Journal of Industrial Medicine, vol. 37, no. 4, pp. 337–362, 1980. View at: Google Scholar
  8. P. I. Jalava, R. O. Salonen, A. S. Pennanen et al., “Heterogeneities in inflammatory and cytotoxic responses of RAW 264.7 macrophage cell line to urban air coarse, fine, and ultrafine particles from six European sampling campaigns,” Inhalation Toxicology, vol. 19, no. 3, pp. 213–225, 2007. View at: Publisher Site | Google Scholar
  9. M. S. Happo, R. O. Salonen, A. I. Hälinen et al., “Dose and time dependency of inflammatory responses in the mouse lung to urban air coarse, fine, and ultrafine particles from six European cities,” Inhalation Toxicology, vol. 19, no. 3, pp. 227–246, 2007. View at: Publisher Site | Google Scholar
  10. E. Brüggemann, H. Gerwig, T. Gnauk, K. Müller, and H. Herrmann, “Influence of seasons, air mass origin and day of the week on size-segregated chemical composition of aerosol particles at a kerbside,” Atmospheric Environment, vol. 43, no. 15, pp. 2456–2463, 2009. View at: Publisher Site | Google Scholar
  11. M. G. Perrone, M. Gualtieri, L. Ferrero et al., “Seasonal variations in chemical composition and in vitro biological effects of fine PM from Milan,” Chemosphere, vol. 78, no. 11, pp. 1368–1377, 2010. View at: Publisher Site | Google Scholar
  12. J. Pey, X. Querol, and A. Alastuey, “Discriminating the regional and urban contributions in the North-Western Mediterranean: PM levels and composition,” Atmospheric Environment, vol. 44, no. 13, pp. 1587–1596, 2010. View at: Publisher Site | Google Scholar
  13. S. Kudo, K. Sekiguchi, K. H. Kim, and K. Sakamoto, “Spatial distributions of ultrafine particles and their behavior and chemical composition in relation to roadside sources,” Atmospheric Environment, vol. 45, pp. 6403–6413, 2011. View at: Publisher Site | Google Scholar
  14. P. A. Steerenberg, L. van Amelsvoort, M. Lovik et al., “Relation between sources of particulate air pollution and biological effect parameters in samples from four european cities: an exploratory study,” Inhalation Toxicology, vol. 18, no. 5, pp. 333–346, 2006. View at: Publisher Site | Google Scholar
  15. M. S. Happo, M. R. Hirvonen, A. I. Hälinen et al., “Seasonal variation in chemical composition of size-segregated urban air particles and the inflammatory activity in the mouse lung,” Inhalation Toxicology, vol. 22, no. 1, pp. 17–32, 2010. View at: Publisher Site | Google Scholar
  16. M. Gualtieri, E. Longhin, M. Mattioli et al., “Gene expression profiling of A549 cells exposed to Milan PM2.5,” Toxicology Letters, vol. 209, pp. 136–145, 2012. View at: Publisher Site | Google Scholar
  17. E. Longhin, E. Pezzolato, P. Mantecca et al., “Season linked responses to fine and quasi-ultrafine Milan PM in cultured cells,” Toxicology in Vitro, vol. 27, pp. 551–559, 2012. View at: Google Scholar
  18. R. B. Hetland, F. R. Cassee, M. Låg, M. Refsnes, E. Dybing, and P. E. Schwarze, “Cytokine release from alveolar macrophages exposed to ambient particulate matter: heterogeneity in relation to size, city an season,” Particle and Fibre Toxicology, vol. 2, article 4, 2005. View at: Publisher Site | Google Scholar
  19. K. F. Chung and I. M. Adcock, “Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction,” European Respiratory Journal, vol. 31, no. 6, pp. 1334–1356, 2008. View at: Publisher Site | Google Scholar
  20. V. Hornung, F. Bauernfeind, A. Halle et al., “Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization,” Nature Immunology, vol. 9, no. 8, pp. 847–856, 2008. View at: Publisher Site | Google Scholar
  21. C. Dostert, V. Pétrilli, R. van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, “Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica,” Science, vol. 320, no. 5876, pp. 674–677, 2008. View at: Publisher Site | Google Scholar
  22. L. Franchi, T. Eigenbrod, R. Muñoz-Planillo, and G. Nuñez, “The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis,” Nature Immunology, vol. 10, no. 3, pp. 241–247, 2009. View at: Publisher Site | Google Scholar
  23. M. A. Kovach and T. J. Standiford, “Toll like receptors in diseases of the lung,” International Immunopharmacology, vol. 11, pp. 1399–1406, 2011. View at: Publisher Site | Google Scholar
  24. S. Becker, L. Dailey, J. M. Soukup, R. Silbajoris, and R. B. Devlin, “TLR-2 is involved in airway epithelial cell response to air pollution particles,” Toxicology and Applied Pharmacology, vol. 203, no. 1, pp. 45–52, 2005. View at: Publisher Site | Google Scholar
  25. K. Schroder and J. Tschopp, “The Inflammasomes,” Cell, vol. 140, no. 6, pp. 821–832, 2010. View at: Publisher Site | Google Scholar
  26. P. Rider, Y. Carmi, O. Guttman et al., “IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation,” Journal of Immunology, vol. 187, no. 9, pp. 4835–4843, 2011. View at: Publisher Site | Google Scholar
  27. S. L. Cassel, S. C. Eisenbarth, S. S. Iyer et al., “The Nalp3 inflammasome is essential for the development of silicosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9035–9040, 2008. View at: Publisher Site | Google Scholar
  28. K. D. Srivastava, W. N. Rom, J. Jagirdar, Y. I. E. Ting-An, T. Gordon, and K. M. Tchou-Wong, “Crucial role of interleukin-1β and nitric oxide synthase in silica-induced inflammation and apoptosis in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 4, pp. 527–533, 2002. View at: Google Scholar
  29. H. B. Yu and B. B. Finlay, “The caspase-1 inflammasome: a pilot of innate immune responses,” Cell Host and Microbe, vol. 4, no. 3, pp. 198–208, 2008. View at: Publisher Site | Google Scholar
  30. W. J. Sandberg, M. Låg, J. A. Holme et al., “Comparison of non-crystalline silica nanoparticles in IL-1ß release from macrophages,” Particle and Fibre Toxicology, vol. 9, article 32, 2012. View at: Publisher Site | Google Scholar
  31. A. S. Yazdi, G. Guarda, N. Riteau et al., “Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19449–19454, 2010. View at: Publisher Site | Google Scholar
  32. T. Morishige, Y. Yoshioka, H. Inakura et al., “The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1β production, ROS production and endosomal rupture,” Biomaterials, vol. 31, no. 26, pp. 6833–6842, 2010. View at: Publisher Site | Google Scholar
  33. E.-J. Yang, S. Kim, J. S. Kim, and I.-H. Choi, “Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles,” Biomaterials, vol. 33, no. 28, pp. 6858–6867, 2012. View at: Publisher Site | Google Scholar
  34. N. Li, T. Xia, and A. E. Nel, “The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles,” Free Radical Biology and Medicine, vol. 44, no. 9, pp. 1689–1699, 2008. View at: Publisher Site | Google Scholar
  35. J. A. Hirota, S. A. Hirota, S. M. Warner et al., “The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter,” Journal of Allergy and Clinical Immunology, vol. 129, pp. 1116–1125, 2012. View at: Publisher Site | Google Scholar
  36. E. J. Park and K. Park, “Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro,” Toxicology Letters, vol. 184, no. 1, pp. 18–25, 2009. View at: Publisher Site | Google Scholar
  37. R. Zhou, A. S. Yazdi, P. Menu, and J. Tschopp, “A role for mitochondria in NLRP3 inflammasome activation,” Nature, vol. 469, pp. 221–225, 2011. View at: Google Scholar
  38. A. Rubartelli, M. Gattorno, M. G. Netea, and C. A. Dinarello, “Interplay between redox status and inflammasome activation,” Trends in Immunology, vol. 32, no. 12, pp. 559–566, 2011. View at: Publisher Site | Google Scholar
  39. M. Gualtieri, A. Franzetti, P. Mantecca et al., “In vitro effects of chemical and microbiological characterized Milan particulate matter,” Procedia Environmental Sciences, vol. 4, pp. 192–197, 2011. View at: Publisher Site | Google Scholar
  40. M. Gualtieri, J. Øvrevik, J. A. Holme et al., “Differences in cytotoxicity versus pro-inflammatory potency of different PM fractions in human epithelial lung cells,” Toxicology in Vitro, vol. 24, no. 1, pp. 29–39, 2010. View at: Publisher Site | Google Scholar
  41. J. L. Kang, C. Moon, H. S. Lee et al., “Comparison of the biological activity between ultrafine and fine titanium dioxide particles in RAW 264.7 cells associated with oxidative stress,” Journal of Toxicology and Environmental Health A, vol. 71, no. 8, pp. 478–485, 2008. View at: Publisher Site | Google Scholar
  42. C. Schorn, B. Frey, K. Lauber et al., “Sodium overload and water influx activate the NALP3 Inflammasome,” Journal of Biological Chemistry, vol. 286, no. 1, pp. 35–41, 2011. View at: Google Scholar
  43. C. Alexander and E. T. Rietschel, “Bacterial lipopolysaccharides and innate immunity,” Journal of Endotoxin Research, vol. 7, no. 3, pp. 167–202, 2001. View at: Publisher Site | Google Scholar
  44. J. A. Mitchell, M. J. Paul-Clark, G. W. Clarke, S. K. McMaster, and N. Cartwright, “Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease,” Journal of Endocrinology, vol. 193, no. 3, pp. 323–330, 2007. View at: Publisher Site | Google Scholar
  45. L. E. Plummer, S. Smiley-Jewell, and K. E. Pinkerton, “Impact of air pollution on lung inflammation and the role of Toll-like receptors,” International Journal of Interferon, Cytokine and Mediator Research, vol. 4, pp. 43–57, 2012. View at: Google Scholar
  46. A. Franzetti, I. Gandolfi, E. Gaspari, R. Ambrosini, and G. Bestetti, “Seasonal variability of bacteria in fine and coarse urban air particulate matter,” Applied Microbiology and Biotechnology, vol. 90, pp. 745–753, 2011. View at: Publisher Site | Google Scholar
  47. E. Naik and V. M. Dixit, “Mitochondrial reactive oxygen species drive proinflammatory cytokine production,” Journal of Experimental Medicine, vol. 208, no. 3, pp. 417–420, 2011. View at: Publisher Site | Google Scholar
  48. F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V. Hornung, “Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome,” Journal of Immunology, vol. 187, no. 2, pp. 613–617, 2011. View at: Publisher Site | Google Scholar
  49. W. P. Arend, “The balance between IL-1 and IL-1Ra in disease,” Cytokine and Growth Factor Reviews, vol. 13, no. 4-5, pp. 323–340, 2002. View at: Publisher Site | Google Scholar
  50. M. Strak, N. A. H. Janssen, K. J. Godri et al., “Respiratory health effects of airborne particulate matter: the role of particle size, composition, and oxidative potential—the RAPTES project,” Environmental Health Perspectives, vol. 120, no. 8, pp. 1183–1189, 2012. View at: Publisher Site | Google Scholar

Copyright © 2013 Rossella Bengalli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1341 Views | 807 Downloads | 31 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder